BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3754533)

  • 1. [We need molsidomine for complete prevention of ischemia. Interview with Prof. Rudolph on the therapy of coronary heart disease].
    Rudolph W
    Fortschr Med; 1986 Apr; 104(13):52. PubMed ID: 3754533
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment with sidnonimine derivatives of chronic ischemic heart disease patients].
    Kuz'ko NV
    Vrach Delo; 1984 Jul; (7):79-81. PubMed ID: 6548063
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical evaluation of molsidomin in ischemic cardiopathy].
    Di Giacomo G; Nicolella U; Puligheddu M; Tripodi A; D'Ascoli C; Di Virgilio D
    Clin Ter; 1984 Oct; 111(2):141-6. PubMed ID: 6239736
    [No Abstract]   [Full Text] [Related]  

  • 4. [Molsidomin in coronary disease. Clinico-pharmacokinetic correlation study on the effect of oral and sublingual therapy].
    Strasser R; Klepzig H; Ostrowski J; Resag K
    MMW Munch Med Wochenschr; 1983 Feb; 125(8):156-8. PubMed ID: 6405248
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effectiveness and duration of effect of molsidomine and isosorbide dinitrate in peripheral circulation].
    König FK; Grewe R; Wörz K
    Fortschr Med; 1985 Oct; 103(38):903-6. PubMed ID: 3908257
    [No Abstract]   [Full Text] [Related]  

  • 6. [Molsidomin and intraocular pressure. No effect in healthy subjects and in glaucoma patients].
    Leydhecker W
    Fortschr Med; 1978 Nov; 96(44):2264-5. PubMed ID: 101432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of coronary heart disease with molsidomine].
    Kaliman J; Uhlir H; Klicpera M
    MMW Munch Med Wochenschr; 1981 Nov; 123(46):1761-2. PubMed ID: 6796846
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect duration and dose-response relation of molsidomine in patients with coronary heart disease].
    Fach WA; Becker HJ
    Z Kardiol; 1984 Oct; 73(10):613-22. PubMed ID: 6393621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proceedings of the International Symposium on Molsidomine. November 5, 1983, Brussels, Belgium.
    Am Heart J; 1985 Mar; 109(3 Pt 2):625-724. PubMed ID: 3838397
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of molsidomine in patients with coronary disease].
    Goch JH; Rosiek S; Brzozowski R; Bała T; Tkaczewski W; Adamska-Dyniewska H
    Pol Tyg Lek; 1985 Jul; 40(29):829-31. PubMed ID: 3903695
    [No Abstract]   [Full Text] [Related]  

  • 11. [Molsidomine in the long-term treatment of angina pectoris].
    Blasini R; Brügmann U; Mannes A; Rudolph W
    Herz; 1982 Oct; 7(5):307-16. PubMed ID: 6818116
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of korvatone on the hemodynamic indices of rheumatism patients].
    Sokolov AM; Suloeva MN
    Vrach Delo; 1984 Jul; (7):83-6. PubMed ID: 6548064
    [No Abstract]   [Full Text] [Related]  

  • 13. [Synergic action of molsidomine and atenolol in patients with exertion angina. Cycloergometric study].
    Gimeno JV; Olagüe J; Bueno FJ; Tellols R; Martín G; Ferrer J
    Med Clin (Barc); 1984 Nov; 83(15):624-8. PubMed ID: 6549203
    [No Abstract]   [Full Text] [Related]  

  • 14. [Anti-ischemic effect of 8 mg molsidomin in retard form].
    Blasini R; Brügmann U; Rudolph W
    Herz; 1984 Dec; 9(6):346-52. PubMed ID: 6392050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Duration of the antianginal effect of oral molsidomine in exertion angina. Double-blind, crossed and randomized study].
    Bordes P; Gimeno JV; Olagüe J; Ferrer J; Hernández M; Algarra F
    Rev Esp Cardiol; 1986; 39(2):138-42. PubMed ID: 3523649
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of molsidomin and nifedipine on tolerance of physical exertion among rheumatic fever patients in the initial stage of heart failure].
    Sokolov AM
    Vrach Delo; 1986 Jan; (1):32-5. PubMed ID: 3754076
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical and hemodynamic effect of molsidomine in patients with unstable angina pectoris].
    Beloev I; Tomov I; Elenkova A; Terzieva L
    Vutr Boles; 1982; 21(3):62-9. PubMed ID: 6810552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The activity of molsidomine in experimental models of ischemic cardiac disease.
    Nitz RE; Martorana PA
    Am Heart J; 1985 Mar; 109(3 Pt 2):631-6. PubMed ID: 3919549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ergometric study of a new vasodilator agent in angina: molsidomine. Value of combination with beta-blockaders].
    Witchitz S; Kolsky H; Moisson P; Valette H
    Arch Mal Coeur Vaiss; 1981 Apr; 74(4):463-71. PubMed ID: 6112971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Corvaton in the ambulatory treatment of patients with angina pectoris].
    Bichan NA
    Klin Med (Mosk); 1984 Oct; 62(10):39-40. PubMed ID: 6549037
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.